Cough, Cold and Allergy (hay Fever) Remedies in USA

Euromonitor International, March 2010, Pages: 54

Cough cold and allergy sales were flat in 2009 following booming growth in 2008. The 13% jump in 2008 was driven by the Zyrtec switch to OTC status. In its first year the product reached sales of US$500 million to become America’s fourth best selling cough, cold and allergy remedy. The brand’s launch was especially impressive considering that a private label alternative was launched at the same time and Claritin, another second generation antihistamine, had already established a strong lead in...

The Cough, Cold and Allergy (Hay Fever) Remedies Products in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Pharyngeal Preparations

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

.

Cough, Cold and Allergy (hay Fever) Remedies in the US
Euromonitor International
March 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Industry Proves Recession-resistant
Fda Flexes Its Muscles
Private Label Proves To Be A Tenacious Competitor
Retailers Focus on Consumer Health
Product Switches Are Expected To Drive Future Growth
US Economic Slowdown Promotes Self-medication
Private Label Proves To Be A Tenacious Competitor
US Food and Drug Agency Asserts Its Weight
OTC Switches Drive Industry Growth
Blurring Lines Between Dietary Supplements, OTC Remedies, Food and Drinks
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Adams Respiratory Therapeutics Inc
Strategic Direction
Key Facts
Summary 3 Adams Respiratory Therapeutics Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Adams Respiratory Theraputics: Competitive Position 2009
Bayer Corp
Strategic Direction
Key Facts
Summary 5 Bayer Corp: Key Facts
Company Background
Competitive Positioning
Summary 6 Bayer Corp: Competitive Position 2009
Chattem Inc
Strategic Direction
Key Facts
Summary 7 Chattem Inc: Key Facts
Summary 8 Chattem Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Chattem, Inc: Competitive Position 2009
General Nutrition Centers Inc
Strategic Direction
Key Facts
Summary 10 General Nutrition Centers Inc: Key Facts
Summary 11 General Nutrition Centers: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 General Nutrition Centers Inc: Competitive Position 2009
GlaxoSmithKline Consumer Health
Strategic Direction
Key Facts
Summary 13 GlaxoSmithKline: Key Facts
Company Background
Production
Competitive Positioning
Summary 14 GlaxoSmithKline Consumer Health: Competitive Position 2009
Johnson & Johnson Inc
Strategic Direction
Key Facts
Summary 15 Johnson & Johnson Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 Johnson & Johnson Inc: Competitive Position 2009
Melaleuca Inc
Strategic Direction
Key Facts
Summary 17 Melaleuca Inc: Key Facts
Summary 18 Melaleuca Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 19 Melaleuca Inc: Competitive Position 2009
Nature's Sunshine Products Inc
Strategic Direction
Key Facts
Summary 20 Nature's Sunshine Products Inc: Key Facts
Summary 21 Nature's Sunshine Products Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 22 Nature's Sunshine Products Inc: Competitive Position 2009
Procter & Gamble Co, the
Strategic Direction
Key Facts
Summary 23 Procter & Gamble: Key Facts
Company Background
Production
Competitive Positioning
Summary 24 Procter & Gamble Co: Competitive Position 2009
Wyeth Consumer Healthcare Inc
Strategic Direction
Key Facts
Summary 25 Wyeth Consumer Healthcare Inc : Key Facts
Company Background
Production
Competitive Positioning
Summary 26 Centrum Consumer Products Inc: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2004-2009
Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2004-2009
Table 14 Sales of Decongestants by Type: Value 2004-2009
Table 15 Sales of Decongestants by Type: % Value Growth 2004-2009
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2004-2009
Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2004-2009
Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2005-2009
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2006-2009
Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2009-2014
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2009-2014

Customers who bought this item also bought

• Pediatric Drugs and Vaccines - Global Business Strategic Report
• Intranasal Drug Delivery - Global Business Strategic Report
• Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
• IV Fluid Transfer Devices Products, Players, Markets and Opportunities
• Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data
• RNA Interference (RNAi) - Global Strategic Business Report
• Antibiotics - Global Strategic Business Report
• Truck Bedliners - Global Strategic Business Report